Artículos de revistas sobre el tema "Thrombotic risk"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Thrombotic risk".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Cheng, Hai, Dian Zhou, Jiang Cao, Wei Chen, Kunming Qi, Kailin Xu y Jianlin Qiao. "A Study about the Relationship between Thrombotic Events and Peripheral Neutrophil-to-Lymphocyte Ratio in Patients with Newly Diagnosed Essential Thrombocythemia". Blood 132, Supplement 1 (29 de noviembre de 2018): 5465. http://dx.doi.org/10.1182/blood-2018-99-112785.
Texto completoMancuso, Salvatrice, Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Alessandro Perez, Florinda Di Piazza, Ada Maria Florena, Antonio Russo y Sergio Siragusa. "The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors". Advances in Hematology 2020 (27 de marzo de 2020): 1–5. http://dx.doi.org/10.1155/2020/9124821.
Texto completoYamamoto, J., T. Taka, K. Yamada, Y. Ijiri, M. Murakami, Y. Hirata, A. Naemura et al. "Tomatoes have natural anti-thrombotic effects". British Journal of Nutrition 90, n.º 6 (diciembre de 2003): 1031–38. http://dx.doi.org/10.1079/bjn2003988.
Texto completoNavarro, Luana Magalhães, Damila Cristina Trufelli, Debora Rodrigues Bonito, Auro Del Giglio y Patricia Weinschenker Bollmann. "Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service". Revista da Associação Médica Brasileira 62, n.º 7 (octubre de 2016): 647–51. http://dx.doi.org/10.1590/1806-9282.62.07.647.
Texto completoChang, Simon, Christian Fynbo Christiansen, Anders Bojesen, Svend Juul, Anna-Marie B. Münster y Claus H. Gravholt. "Klinefelter syndrome and testosterone treatment: a national cohort study on thrombosis risk". Endocrine Connections 9, n.º 1 (enero de 2020): 34–43. http://dx.doi.org/10.1530/ec-19-0433.
Texto completoHenni, Samir, Pierre Ramondou, Guillaume Duval, Jean Picquet, Georges Leftheriotis y Pierre Abraham. "The risk of lower-limb superficial vein thrombosis relative to lower-limb venous thrombotic events is not increased in winter months". Phlebology: The Journal of Venous Disease 35, n.º 7 (10 de enero de 2020): 533–37. http://dx.doi.org/10.1177/0268355519896729.
Texto completoLim, Sunghee, Ji Yoon Lee, Seok Jin Kim y Won Seog Kim. "The International Prognostic Index Is a Better Predictor of Thrombotic Complications Than the Khorana Score for Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Results of a Single Center Prospective Cohort Study". Blood 120, n.º 21 (16 de noviembre de 2012): 5095. http://dx.doi.org/10.1182/blood.v120.21.5095.5095.
Texto completoMiller, Mariel, Kamil K. Khanipov, Christopher Zahner y George K. Golovko. "Increased Risk of Thrombosis in Patients with Polycystic Ovarian Syndrome". Blood 142, Supplement 1 (28 de noviembre de 2023): 5544. http://dx.doi.org/10.1182/blood-2023-190997.
Texto completoKreidy, Raghid. "Pathophysiology of Post-Thrombotic Syndrome: The Effect of Recurrent Venous Thrombosis and Inherited Thrombophilia". ISRN Vascular Medicine 2011 (9 de noviembre de 2011): 1–4. http://dx.doi.org/10.5402/2011/513503.
Texto completoPark, D. J., S. E. Choi, H. Xu, J. H. Kang y S. S. Lee. "AB0442 RISK FACTORS ASSOCIATED WITH THROMBOTIC EVENTS IN KOREAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1519.3–1520. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1674.
Texto completoSiddiqui, Nadeem A., Ziad Sophie, Farhan Zafar, Delvene Soares y Iram Naz. "Predictors for the development of post-thrombotic syndrome in patients with primary lower limb deep venous thrombosis: A case–control study". Vascular 25, n.º 1 (10 de julio de 2016): 10–18. http://dx.doi.org/10.1177/1708538116636250.
Texto completoVassalli, Laura Coutinho, Emilia Carolina Malafaia, Maria L. Chauffaille y Daniella Kerbauy. "Leukocytosis Can Predict Thrombotic Events in Myelofibrosis". Blood 126, n.º 23 (3 de diciembre de 2015): 5191. http://dx.doi.org/10.1182/blood.v126.23.5191.5191.
Texto completoSiscovick, David, Frits Rosendaal y Alexander Reiner. "Hemostatic Risk Factors and Arterial Thrombotic Disease". Thrombosis and Haemostasis 85, n.º 04 (2001): 584–95. http://dx.doi.org/10.1055/s-0037-1615638.
Texto completoDho-Nagy, Eszter-Anna, Attila Brassai, Patrick Lechsner, Corina Ureche y Erika-Gyöngyi Bán. "COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk". International Journal of Molecular Sciences 25, n.º 2 (9 de enero de 2024): 818. http://dx.doi.org/10.3390/ijms25020818.
Texto completoPuetz, John, Ginger Darling, Petr Brabec, Jan Blatny y Prasad Mathew. "The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa." Blood 110, n.º 11 (16 de noviembre de 2007): 3193. http://dx.doi.org/10.1182/blood.v110.11.3193.3193.
Texto completoKhidirova, L. D., N. P. Ilyinykh y P. G. Madonov. "Thrombosis on background of COVID-19 in middle-aged people". Medical alphabet, n.º 19 (16 de octubre de 2022): 38–43. http://dx.doi.org/10.33667/2078-5631-2022-19-38-43.
Texto completoRoach, Rachel E. J., Willem M. Lijfering, Astrid van Hylckama Vlieg, Frans M. Helmerhorst, Frits R. Rosendaal y Suzanne C. Cannegieter. "The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors". Blood 122, n.º 26 (19 de diciembre de 2013): 4264–69. http://dx.doi.org/10.1182/blood-2013-07-518159.
Texto completoHobbs, Gabriela Soriano, Minal Patel, Young Rock Chung, Omar Abdel-Wahab, Gerald A. Soff y Raajit K. Rampal. "Identification Of Markers Of Thrombotic Risk and Response To Cytoreductive Intervention In Philadelphia-Chromosome Negative Myeloproliferative Neoplams". Blood 122, n.º 21 (15 de noviembre de 2013): 3627. http://dx.doi.org/10.1182/blood.v122.21.3627.3627.
Texto completoRadaelli, Franca, Stefania Bramanti, Mariangela Colombi, Alessandra Iurlo y Alberto Zanella. "Essential Thrombocythemia: Analysis of Risk Factors for Thrombotic Events in a Series of 306 Patients." Blood 106, n.º 11 (16 de noviembre de 2005): 4937. http://dx.doi.org/10.1182/blood.v106.11.4937.4937.
Texto completoLim, Wendy. "Prevention of thrombosis in antiphospholipid syndrome". Hematology 2016, n.º 1 (2 de diciembre de 2016): 707–13. http://dx.doi.org/10.1182/asheducation-2016.1.707.
Texto completoBertina, Rogier. "Genetic Approach to Thrombophilia". Thrombosis and Haemostasis 86, n.º 07 (2001): 92–103. http://dx.doi.org/10.1055/s-0037-1616205.
Texto completoWang, Xuekun, Yansong Tu, Mei Cao, Xiaoyan Jiang, Yazhi Yang, Xiaoyan Zhang, Hurong Lai, Huaijun Tu y Jian Li. "The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events". BioMed Research International 2022 (8 de agosto de 2022): 1–8. http://dx.doi.org/10.1155/2022/9343951.
Texto completoHeda, Pooja Prakash y Ali Jafer Nejim Al-Hilly. "Thrombotic Events in Covid-19: Incidence and their Association with Lab Parameters, Vaccination Status and Mortality". Journal of the Bahrain Medical Society 34, n.º 4 (2022): 1–10. http://dx.doi.org/10.26715/jbms.34_4_1.
Texto completoChoudry, Qamar Un-Nisa, Raheel Iftikhar, Manzur Qadir, Tariq Mehmood Satti, Ghassan Omair y Syed Kamran Mehmood. "HIGH ALTITUDE AND VENOUS THROMBOSIS: FREQUENCY AND RISK FACTORS". PAFMJ 71, n.º 1 (24 de febrero de 2021): 107–11. http://dx.doi.org/10.51253/pafmj.v71i1.3173.
Texto completoCohen, Kenneth Roy, David Anderson, Sheng Ren y David J. Cook. "Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study". BMJ Open 12, n.º 2 (febrero de 2022): e051624. http://dx.doi.org/10.1136/bmjopen-2021-051624.
Texto completoMirrakhimov, Aibek E., Alaa M. Ali, Aram Barbaryan, Suartcha Prueksaritanond y Nasir Hussain. "Primary Nephrotic Syndrome in Adults as a Risk Factor for Pulmonary Embolism: An Up-to-Date Review of the Literature". International Journal of Nephrology 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/916760.
Texto completoPalacios-Acedo, Ana-Luisa, Mélanie Langiu, Lydie Crescence, Diane Mège, Christophe Dubois y Laurence Panicot-Dubois. "Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types". Cancers 14, n.º 3 (30 de enero de 2022): 730. http://dx.doi.org/10.3390/cancers14030730.
Texto completoCedrone, Michele, Barbara Anaclerico, Francesca Paoloni, Roberto Latagliata, Marco Montanaro, Francesca Spirito, Sabrina Leonetti Crescenzi et al. "Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms". Blood 126, n.º 23 (3 de diciembre de 2015): 2821. http://dx.doi.org/10.1182/blood.v126.23.2821.2821.
Texto completoKharlamova, E. N., T. M. Reshetnyak y G. M. Tarasova. "Thrombosis risk factors in ANCA-associated vasculitis". Modern Rheumatology Journal 17, n.º 2 (22 de abril de 2023): 93–99. http://dx.doi.org/10.14412/1996-7012-2023-2-93-99.
Texto completoSeck, Moussa, Elimane Seydi Bousso, Sokhna Aissatou Touré, Abibatou Sall, Maryama Ndao, Sérigne Mourtalla Guèye, Blaise Félix Faye et al. "Thrombotic Events and Risk Factors for Thrombosis in Polycythemia in Senegal, West Africa". Journal of Clinical Haematology 4, n.º 1 (5 de junio de 2023): 1–8. http://dx.doi.org/10.33696/haematology.4.052.
Texto completoKahn, Susan R. "The post-thrombotic syndrome". Hematology 2016, n.º 1 (2 de diciembre de 2016): 413–18. http://dx.doi.org/10.1182/asheducation-2016.1.413.
Texto completoRuffatti, A., T. Del Ross, M. Ciprian, M. Nuzzo, M. Rampudda, M. T. Bertero, R. Bergia et al. "Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study". Annals of the Rheumatic Diseases 68, n.º 3 (23 de septiembre de 2008): 397–99. http://dx.doi.org/10.1136/ard.2008.096669.
Texto completoChaireti, Roza y Hareth Nahi. "Risk Factors and Risk Stratification of Thromboembolic Risk in Patients with Multiple Myeloma". Hemato 3, n.º 3 (29 de agosto de 2022): 518–26. http://dx.doi.org/10.3390/hemato3030036.
Texto completoMancini, Mariangela, Gianmarco Randazzo, Gregory Piazza y Fabrizio Dal Moro. "Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction". Biomedicines 10, n.º 10 (21 de septiembre de 2022): 2354. http://dx.doi.org/10.3390/biomedicines10102354.
Texto completoZhang, Xueya, Xuerong Cai y Jingxin Pan. "Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms". Clinical and Applied Thrombosis/Hemostasis 26 (1 de enero de 2020): 107602962093520. http://dx.doi.org/10.1177/1076029620935207.
Texto completoBuxhofer-Ausch, Veronika, Heinz Gisslinger, Juergen Thiele, Bettina Gisslinger, Hans-Michael Kvasnicka, Leonhard Müllauer, Sophie Frantal et al. "Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients",. Blood 118, n.º 21 (18 de noviembre de 2011): 3846. http://dx.doi.org/10.1182/blood.v118.21.3846.3846.
Texto completoGrover, Steven P., Yohei M. Hisada, Raj S. Kasthuri, Brandi N. Reeves y Nigel Mackman. "Cancer Therapy–Associated Thrombosis". Arteriosclerosis, Thrombosis, and Vascular Biology 41, n.º 4 (abril de 2021): 1291–305. http://dx.doi.org/10.1161/atvbaha.120.314378.
Texto completoSrisuwananukorn, Andrew, Rasha Raslan, Xu Zhang, Binal N. Shah, Jin Han, Michel Gowhari, Robert E. Molokie, Victor R. Gordeuk y Santosh L. Saraf. "Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease". Blood Advances 4, n.º 9 (8 de mayo de 2020): 1978–86. http://dx.doi.org/10.1182/bloodadvances.2019001384.
Texto completoVera, Rodrigo Hernández, Gemma Vilahur y Lina Badimon. "Obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker fatty rats". Thrombosis and Haemostasis 109, n.º 02 (2013): 319–27. http://dx.doi.org/10.1160/th12-09-0696.
Texto completoPósfai, Éva, Imelda Marton, Attila Nemes y Zita Borbényi. "Thrombotic events and importance of IPSET thrombosis risk evaluation score in essential thrombocythaemia". Orvosi Hetilap 156, n.º 14 (abril de 2015): 558–63. http://dx.doi.org/10.1556/oh.2015.30117.
Texto completoMishcheniuk, O. Y., O. M. Kostiukevych, L. K. Benkovska y A. N. Kravchenko. "THE CONTRIBUTION OF CARRIER THE ALLELIC VARIANT G1691A OF THE GENE V OF COAGULATION FACTOR TO THE DEVELOPMENT OF THROMBOTIC COMPLICATIONS DEPENDING ON THE PRESENCE OF CARDIOVASCULAR RISK FACTORS IN INDIVIDUALS WITH SECONDARY LEUKOCYTOSIS, THROMBOCYTOSIS A". Клінічна та профілактична медицина 4, n.º 9-10 (17 de octubre de 2019): 61–67. http://dx.doi.org/10.31612/2616-4868.3(9).2019.08.
Texto completoAlabyad, Darwish, Srikant Rangaraju, Michael Liu, Rajeel Imran, Christine L. Kempton, Milad Sharifpour, Sara C. Auld et al. "Validation of an admission coagulation panel for risk stratification of COVID-19 patients". PLOS ONE 16, n.º 3 (19 de marzo de 2021): e0248230. http://dx.doi.org/10.1371/journal.pone.0248230.
Texto completoCattaneo, Marco. "Hyperhomocysteinemia, Atherosclerosis and Thrombosis". Thrombosis and Haemostasis 81, n.º 02 (1999): 165–76. http://dx.doi.org/10.1055/s-0037-1614438.
Texto completoFranchini, Massimo. "Thrombotic complications in patients with hereditary bleeding disorders". Thrombosis and Haemostasis 92, n.º 08 (2004): 298–304. http://dx.doi.org/10.1160/th04-03-0148.
Texto completoDeRoo, Scott, K. Barry Deatrick y Peter Henke. "The vessel wall: A forgotten player in post thrombotic syndrome". Thrombosis and Haemostasis 104, n.º 10 (2010): 681–92. http://dx.doi.org/10.1160/th10-03-0183.
Texto completoCortelazzo, S., P. Viero, G. Finazzi, A. D'Emilio, F. Rodeghiero y T. Barbui. "Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia." Journal of Clinical Oncology 8, n.º 3 (marzo de 1990): 556–62. http://dx.doi.org/10.1200/jco.1990.8.3.556.
Texto completoZapletal, Ondrej, Jan Blatny y Eva Janousova. "Inherited Pro-Thrombotic Risk Factors in Children of South Moravia Region, Czech Republic". Blood 120, n.º 21 (16 de noviembre de 2012): 5136. http://dx.doi.org/10.1182/blood.v120.21.5136.5136.
Texto completoLugacheva, Yu G., I. V. Kulagina, I. A. Kovalev, Ye V. Krivoschekov, O. S. Yanulevich y T. E. Suslova. "Risk factors of thrombotic complications in patients with single functional ventricle". Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 64, n.º 2 (15 de mayo de 2019): 68–74. http://dx.doi.org/10.21508/1027-4065-2019-64-2-68-74.
Texto completoCapecchi, Marco, Alessandro Ciavarella, Andrea Artoni, Maria Abbattista y Ida Martinelli. "Thrombotic Complications in Patients with Immune-Mediated Hemolysis". Journal of Clinical Medicine 10, n.º 8 (18 de abril de 2021): 1764. http://dx.doi.org/10.3390/jcm10081764.
Texto completoLINDQVIST, PELLE, BJÖRN DAHLBÄCK y KAREL MARŜÁL. "Thrombotic Risk During Pregnancy". Obstetrics & Gynecology 94, n.º 4 (octubre de 1999): 595–99. http://dx.doi.org/10.1097/00006250-199910000-00021.
Texto completo